{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-081977","form_type":"8-K","ticker":"CERO","cik":"0001870404","company_name":"CERO THERAPEUTICS HOLDINGS, INC.","filed_at":"2024-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.035421+00:00","generated_at":"2026-05-31T01:40:27.156855+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"CERo Therapeutics cancels Sep 26 special meeting for reverse stock split, to refile","bullets":["Special meeting of stockholders scheduled for September 26, 2024, has been canceled.","Reverse stock split proposal (range 1-for-25 to 1-for-150) withdrawn for now.","Company will file a new proxy statement for a future special meeting on the reverse split.","Original proxy statement filed August 26, 2024; no vote will occur as planned."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-081977","json":"https://secwatch.observer/filing/0001213900-24-081977.json","markdown":"https://secwatch.observer/filing/0001213900-24-081977.md","text":"https://secwatch.observer/filing/0001213900-24-081977.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024081977/0001213900-24-081977-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024081977/ea0215745-8k_cerothera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:40:27.156855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}